Factors associated with total laryngectomy following organ-preserving treatment of laryngeal SCC.

Veterans Affairs laryngeal squamous cell carcinoma larynx preservation recurrence salvage laryngectomy

Journal

Laryngoscope investigative otolaryngology
ISSN: 2378-8038
Titre abrégé: Laryngoscope Investig Otolaryngol
Pays: United States
ID NLM: 101684963

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 14 02 2024
revised: 25 06 2024
accepted: 20 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: epublish

Résumé

A subset of laryngeal squamous cell carcinoma (LSCC) patients undergoing larynx preserving treatment ultimately require total laryngectomy (TL) for oncologic or functional reasons. This study aims to identify TL risk factors in these patients. Retrospective cohort study using Veterans Affairs (VA) database. T1-T4 LSCC cases treated with primary radiotherapy (XRT) or chemoradiotherapy (CRT) were assessed for TL and recurrence. Binary logistic and Cox regression and Kaplan-Meier analyses were implemented. Of 5390 cases, 863 (16.0%) underwent TL. On multivariable analysis, age (adjusted odds ratio: 0.97 [0.96-0.98]; Advanced nodal stage was associated with reduced rates of salvage TL in the setting of local recurrence, and subsequent worse prognosis after recurrence. Conversely, advanced nodal stage may increase the risk for functional salvage TL in patients without recurrence. Level 3.

Identifiants

pubmed: 39108948
doi: 10.1002/lio2.1317
pii: LIO21317
pmc: PMC11301822
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e1317

Informations de copyright

© 2024 The Author(s). Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Mitchell T Victor (MT)

University of California San Diego School of Medicine San Diego California USA.
Northwestern University, Feinberg School of Medicine Chicago Illinois USA.

Farhoud Faraji (F)

Department of Otolaryngology-Head and Neck Surgery University of California San Diego Health La Jolla California USA.
Hanna and Mark Gleiberman Head and Neck Cancer Center, Moores Cancer Center University of California San Diego Health La Jolla California USA.

Rohith Voora (R)

Department of Otolaryngology-Head and Neck Surgery University of California San Diego Health La Jolla California USA.

Sandhya Kalavacherla (S)

University of California San Diego School of Medicine San Diego California USA.

Loren K Mell (LK)

Hanna and Mark Gleiberman Head and Neck Cancer Center, Moores Cancer Center University of California San Diego Health La Jolla California USA.
Department of Radiation Medicine and Applied Sciences University of California San Diego Health La Jolla California USA.

Brent S Rose (BS)

Department of Radiation Medicine and Applied Sciences University of California San Diego Health La Jolla California USA.
Department of Radiation Oncology Veterans Affairs San Diego Healthcare System San Diego California USA.

Theresa W Guo (TW)

Department of Otolaryngology-Head and Neck Surgery University of California San Diego Health La Jolla California USA.
Hanna and Mark Gleiberman Head and Neck Cancer Center, Moores Cancer Center University of California San Diego Health La Jolla California USA.

Classifications MeSH